SCHEMBL17898505

SCHEMBL17898505

Nc1ccc2cc(C(=O)ON3C(=O)CCC3=O)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMYD3 Q9H7B4 1/20 0.41
PLAU P00749 1/20 0.39
MAPK1 P28482 1/20 0.35
CDYL2 Q8N8U2 1/20 0.35
CDYL Q9Y232 1/20 0.35
SRD5A1 P18405 1/20 0.35
SRD5A2 P31213 1/20 0.35
ALDH1A1 P00352 4/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HSD17B10 Q99714 3/20 0.34
CYP3A4 P08684 2/20 0.34
KMT2A Q03164 2/20 0.33
LMNA P02545 2/20 0.33
HRH3 Q9Y5N1 1/20 0.33
ALOX15 P16050 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HBB P68871 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1231850 0.85 CES2 (0.49) MAPK1CDYL2CDYLALDH1A1NPC1
SCHEMBL12216547 0.84 LMNA (0.44) ALDH1A1NPC1RAB9AHSD17B10CYP3A4
SCHEMBL9551376 0.84 KMT2A (0.44) MAPK1ALDH1A1NPC1RAB9AHSD17B10
SCHEMBL12444640 0.84 CES2 (0.43) MAPK1CDYL2CDYLNPC1RAB9A
SCHEMBL17898506 0.80 CYP3A4 (0.41) ALDH1A1NPC1RAB9AHSD17B10CYP3A4
SCHEMBL9551402 0.79 GLA (0.48) KDM4EHSD17B10KMT2ALMNATDP1
SCHEMBL300884 0.79 CA12 (0.42) MAPK1ALDH1A1RAB9AKDM4EKMT2A
SCHEMBL2575984 0.78 KDM4E (0.41) MAPK1ALDH1A1NPC1KDM4ECYP3A4
SCHEMBL4888250 0.77 SLC6A3 (0.40) MAPK1ALDH1A1NPC1RAB9AKDM4E
SCHEMBL20804144 0.77 CYP3A4 (0.41) ALDH1A1NPC1RAB9AHSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9977024-B2 Targeted covalent probes and inhibitors of proteins containing redox-sensitive cysteines THE SCRIPPS RESEARCH INSTITUTE (US) 2018-05-22 US disclosed
US-9977024-B2 Targeted covalent probes and inhibitors of proteins containing redox-sensitive cysteines THE SCRIPPS RESEARCH INSTITUTE (US) 2018-05-22 US disclosed
US-20160195532-A1 Targeted Covalent Probes and Inhibitors of Proteins Containing Redox-Sensitive Cysteines THE SCRIPPS RESEARCH INSTITUTE 2016-07-07 US disclosed
US-20160195532-A1 Targeted Covalent Probes and Inhibitors of Proteins Containing Redox-Sensitive Cysteines THE SCRIPPS RESEARCH INSTITUTE 2016-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160195532-A1 Targeted Covalent Probes and Inhibitors of Proteins Containing Redox-Sensitive Cysteines PTMS, RSU1, QSOX1 SMYD3 2000/4885PLAU 4648/4885MAPK1 986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.